CooperSurgical, Inc.

FDA inspection history across 2 sites, 2015 to 2024

2
Form 483s
1
Close-out
1
Warning letter

Every document, by year

  • Form 483
  • Close-out
  • Warning letter

2015: one warning letter; 2017: one close-out letter; 2022: one Form 483; 2024: one Form 483.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2015–17One warning letter and one close-out letter, at Stafford, Texas.
  2. 2022–24Two Form 483s, at North Tonawanda, New York.
  3. 2022The longest 483 on file: 5 observations over 7 pages at North Tonawanda, New York.

Cited most

Across all CooperSurgical observations on file

The complete CooperSurgical file.

All 4 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$396

The price of the documents, added to your cart together

Sites

Also: one document not tied to a site.

Documents

4 on file, newest first
DateDocumentPrice
2024-02-01483 Form 483$99
2022-03-04483 Form 483$99
2017-09-12Close-out Close-out letter$99
2015-06-09Warning letter Warning letter$99

Investigators on these documents

Matthew D. Schnittker (1)

FEI number 1316626 · most recent document Feb 1, 2024

About CooperSurgical, Inc.

How many FDA Form 483s has CooperSurgical, Inc. received?

FDA Intel has 2 Form 483s on file for CooperSurgical, Inc.; the most recent is dated Feb 1, 2024.

When was CooperSurgical, Inc. last inspected by FDA?

The most recent FDA inspection document on file for CooperSurgical, Inc. is a Form 483 dated Feb 1, 2024, for the site in North Tonawanda, New York.

What did FDA cite at CooperSurgical, Inc.?

The regulations cited most in the observations on file for CooperSurgical, Inc. are 21 CFR 211.192 (Production record review), 2 times; 21 CFR 211.160(b) (General requirements), 1 time; 21 CFR 211.198(b)(2) (Complaint files), 1 time.

Has CooperSurgical, Inc. received an FDA warning letter?

Yes. FDA Intel has 1 FDA warning letter on file for CooperSurgical, Inc.; the most recent is dated Jun 9, 2015.